Login / Signup

Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatment.

Ching-Tso ChenYin-Hsun FengChia-Jui YenSan-Chi ChenYun-Tzu LinLi-Chun LuChih-Hung HsuAnn-Lii ChengYu-Yun Shao
Published in: Hepatology international (2022)
Receiving second-line therapy and good liver reserve were associated with favorable PFLS after the failure of first-line Atezo-Bev treatment.
Keyphrases
  • stem cells
  • combination therapy
  • replacement therapy
  • chemotherapy induced